Skin News and Research

RSS

Insights on diagnosing and treating scabies, bedbugs, and lice effectively

Research in outlines the causes and treatments for scabies, bedbugs, and body lice, stressing the importance of accurate diagnosis and social factors.

10 Sep 2024

Long-term exercise leads to healthier fat storage in obese individuals

People with obesity who are long-time exercisers have healthier belly fat tissue and can store fat there more effectively than nonexercisers with obesity, according to a new study from a team of researchers at the University of Michigan.

10 Sep 2024

Timing of nocturnal hot flashes may impact heart disease risk

Nocturnal hot flashes are disruptive regardless of when they occur during the night. A new study suggests that more hot flashes occur during the second half of the night when more REM sleep typically occurs and when such disruption has a greater chance of increasing the risk of heart disease.

10 Sep 2024

Researchers uncover clues to the mechanism behind vitiligo

Skin pigmentation disorders affect people across the world. One of them, vitiligo, is said to have a worldwide incidence of 1-2%.

10 Sep 2024

Expert survey unveils underestimated health impacts of weather and climate on mortality

The study analyzes expert views on climate's role in mortality, linking weather hazards to health outcomes and highlighting urgent preventive strategies.

10 Sep 2024

Sweden reports drop in skin cancer rates for under 50s

The risk of skin cancer, malignant melanoma, now appears to be decreasing in Sweden - at least in those under 50, according to a new study.

9 Sep 2024

New hydrogel system could extend semaglutide dosing to once a month for type 2 diabetes patients

French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and weight control drug semaglutide to just once a month, according to new research to be presented at this year's annual meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

9 Sep 2024

New study finds skincare products could expose children to harmful phthalates

Children's skincare products are linked to urinary phthalate levels.

9 Sep 2024

Age-related fibroblast changes in males drive aggressive melanoma

Age-related changes in the fibroblasts, cells that create the skin's structure, contribute to the development of aggressive, treatment-resistant melanoma in males, according to research in mice by the Johns Hopkins Kimmel Cancer Center.

6 Sep 2024

Understanding the cooperation of transcription factors in gene expression

Every cell in our body contains the same DNA, yet liver cells are different from brain cells, and skin cells differ from muscle cells.

6 Sep 2024

Breakthrough technique enables clear visualization of organs in the body

Researchers have developed a new way to see organs within a body by rendering overlying tissues transparent to visible light.

6 Sep 2024

Study reveals key bacteria for developing personalized probiotics for newborns

Newborn babies have one of three pioneer bacteria in their gut shortly after birth, one of which could be used to develop new personalized infant therapeutic probiotics, researchers show.

6 Sep 2024

Wearable activity trackers show promise in detecting early signals of disease

Fitbit, Apple Watch or Oura ring, wearable technology is in high demand among the health conscious. But beyond measuring heart rates and blood pressure, could fitness trackers be used to test for and effectively screen for disease?

6 Sep 2024

The impact of microgravity on cancer development and treatment

The Wake Forest Institute for Regenerative Medicine (WFIRM) is honored to announce its selection for a pioneering cancer research project that will take place aboard the International Space Station (ISS). The project, one of only five chosen through a competitive solicitation by the ISS National Lab in partnership with NASA, aims to explore the effects of microgravity on cancer development and treatment.

6 Sep 2024

Cancer drug offers life-changing results for severe lupus patient

The team at Charité – Universitätsmedizin Berlin is astounded by the huge improvement seen in a female patient with severe systemic lupus erythematosus (SLE) after being treated with the cancer medication teclistamab. Not long ago, the 23-year-old was wheelchair-bound due to the autoimmune disease.

6 Sep 2024